Analyser demonstrates excellent performance in evaluation study

Quo-Lab meets strict international quality targets – confirming it fit for purpose for diabetes testing

FDA clearance given for haemoglobin analyser

Easy to use, reagent-free analyser cleared for use in POC & CLIA waived settings

Mobile data management for haemoglobin analyser

New data management smartphone application enhances DiaSpect Tm’s use for rapid, remote haemoglobin analysis

Assay is FDA cleared and validated

EKF Procalcitonin assay FDA cleared and validated for Beckman AU chemistry analysers

Connectivity solution for point-of-care analysers

Point-of-care HbA1c analysers to transmit patient data to the majority of LIMS and HIS

Novel diabetic biomarker test

Glycated Serum Protein assay provides simple, sensitive and fast alternative glycemic monitoring test

Specific biomarker test for early sepsis identification

The EKF-Stanbio Procalcitonin LiquiColor Assay aids in viral and bacterial infection differentiation

New sepsis biomarker and POC haemoglobin analyser

EKF launching sepsis biomarker and POC haemoglobin analyser at Medica 2014

Non-invasive cancer diagnosis and monitoring

EKF Molecular and Massachusetts General Hospital announce circulating tumour cell clinical research collaboration

Monitoring HbA1c in diabetes patients

European Reference Laboratory for Glycohemoglobin study reaffirms EKF’s Quo-Test meets HbA1c performance criteria

Point-of-care analyser meets all standards set by independent certifying bodies

The Quo-Lab analyser offers laboratory accurate results from just 4µL of blood with a user friendly interface





To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited